Zeincro has joined forces with Excelya to provide comprehensive services across Europe that will best serve our customers’ needs. Together, we have become The Excelya Group.

News & Events
Send to a friend
ZEINCRO appoints Mrs. Sophia Romboli as Country Manager in Greece

Sophia Romboli, following a very successful tenure as ZEINCRO’s Head of Functional Service Provider Department will be promoted to Country Manager for Greece, effective April 1st, 2016. As Country Manager, Sophia’s main responsibilities will be to lead and coordinate the Greek Operations towards the direction of ZEINCRO’s strategic goals, grow its footprint in the Greek market, while driving its execution capabilities.

Sophia has an extensive experience and proven track record in the Healthcare industry, having held various senior positions in international CROs and Pharma companies. Prior to joining ZEINCRO, Sophia spent over 12 years in Clinical Trials gaining expertise in many therapeutic areas and types of Clinical Trials. Since 2011, Sophia has been heading ZEINCROs FSP Department, with great success resulting in a number of international awards for the Department. Sophia holds a Bachelor Degree in Biology and a PhD in Biochemistry from the Medical School of the University of Athens.

As part of its growth strategy, ZEINCRO continuously enforces its leadership team, with high caliber professionals and promotes internal talent, driving the Group towards its commitment to strengthen its international perspective and offer an unmatched combination of quality and know-how to its customers.

“It’s a privilege to see extraordinary talent rise to the opportunity to grow within our organization and lead the future our Group key areas of Operations.”, quoted Mr K. Karakostas, ZEINCRO’s Group GM.

“Throughout the years, Sophia proved in the best possible way her leadership skills and deep understanding of the opportunities and challenges in today’s Clinical Trials market in Greece. Under her new responsibilities Sophia will play an instrumental role in guiding our operations in Greece and in achieving maximum value for our customers”, commented Prof. Gregory Sivolapenko, Director of ZEINCRO.



ZEINCRO is a leading Contract Research Organization (CRO) with a main emphasis in the region of Central­ and South-­Eastern Europe, but also global capabilities in services such as Safety and Pharmacovigilance and Late Phase. With sixteen years of experience in successful clinical research projects in the region, ZEINCRO has developed a thorough understanding of the communities and the regions in which it operates and has established strong professional links with local healthcare stakeholders. This approach allows ZEINCRO to set new standards for successful clinical trials by delivering bespoke services that are flexible, ethical and maximize patient recruitment and compliance. ZEINCRO manages to balance productivity and quality incorporating added value techniques based on each country’s local knowledge. ZEINCRO provides clinical trial services to the global drug development industry and offers additional services in post marketing safety and efficacy studies, regulatory affairs and pharmacovigilance including risk management plans.


For more information, visit www.zeincro.com


ZEINCRO is a leading contract research organization covering more than 21 countries in Europe, with a special focus in the region of Central and South Eastern Europe (Albania, Austria, Bulgaria, Cyprus, Czech Republic, Germany, Estonia, FYROM, Greece, Hungary, Latvia, Lithuania, Malta, Moldova, the Netherlands, Poland, Romania, Slovakia, Switzerland, Turkey and Ukraine).

Read more


  • Email:  info@zeincro.com

ZEINCRO : member of

European CRO Federation (EUCROF)

© 2012-2021 ZEINCRO Group - All rights reserved.
Developed by LogicONE